NASDAQ:GTHX
G1 Therapeutics Inc Stock News
$4.27
-0.220 (-4.90%)
At Close: May 06, 2024
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:30pm, Monday, 02'nd May 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exerci
Earnings Preview: G1 Therapeutics (GTHX) Q1 Earnings Expected to Decline
07:03pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
G1 Therapeutics (GTHX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: G1 Therapeutics (GTHX) Q1 Earnings Expected to Decline
04:49pm, Wednesday, 27'th Apr 2022
G1 Therapeutics (GTHX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
G1 Therapeutics: Needs To Expand Labels And Commercialize Better
01:39pm, Wednesday, 27'th Apr 2022
GTHX has stayed depressed because of lack of successful commercialization. It also needs to expand labels into larger indications.
G1 Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 4, 2022
12:30pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a corpo
G1 Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 4, 2022
08:30am, Thursday, 21'st Apr 2022
RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a corpora
G1 Therapeutics to Participate in the 21st Annual Needham Virtual Healthcare Conference
03:30pm, Wednesday, 06'th Apr 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., April 06, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that Jack Bailey and Raj Malik, M.D., G1�
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:15pm, Friday, 01'st Apr 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., April 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exer
New Real-World Data Show Potential of Trilaciclib to Reduce the Substantial Burden of Myelosuppression in Patients with Extensive-Stage Small-Cell Lung Cancer Treated with Chemotherapy
08:05pm, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
Data being presented at the National Comprehensive Cancer Network (NCCN) 2022 Annual Conference Data being presented at the National Comprehensive Cancer Network (NCCN) 2022 Annual Conference
MeiraGTx Holdings PLC (MGTX) Stock Jumps 6.5%: Will It Continue to Soar?
10:46am, Wednesday, 30'th Mar 2022 Zacks Investment Research
MeiraGTx Holdings PLC (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
G1 Therapeutics reports inducement grants
10:49pm, Tuesday, 01'st Mar 2022 Seeking Alpha
G1 Therapeutics (GTHX) granted stock options exercisable for a total 10.8K common shares and an aggregate of 8.8K restricted stock units (RSUs) to four employeesThe options were…
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10:00pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exer
G1 Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference and the 34th Annual Roth 2022 Conference
04:15pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two u
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
01:01pm, Thursday, 24'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Adagio Appoints COO David Hering As Interim CEO
Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
